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Coeliac disease is an intolerance triggered by the ingestion of wheat gluten proteins. It is of increasing
concern to consumers and health professionals as its incidence appears to be increasing. The amino acid
sequences in gluten proteins that are responsible for triggering responses in sensitive individuals have
been identiﬁed showing that they vary in distribution among and between different groups of gluten
proteins. Conventional breeding may therefore be used to select for gluten protein fractions with lower
contents of coeliac epitopes. Molecular breeding approaches can also be used to speciﬁcally down-
regulate coeliac-toxic proteins or mutate coeliac epitopes within individual proteins. A combination of
these approaches may therefore be used to develop a “coeliac-safe” wheat. However, this remains a
formidable challenge due to the complex multigenic control of gluten protein composition. Furthermore,
any modiﬁed wheats must retain acceptable properties for making bread and other processed foods. Not
surprisingly, such coeliac-safe wheats have not yet been developed despite over a decade of research.
© 2015 The Authors. Published by Elsevier Ltd. This is an open access article under the CC BY license
(http://creativecommons.org/licenses/by/4.0/).1. Introduction
1.1. The importance of wheat in human nutrition and health
Cereals are the most widely grown and consumed staple foods
in the world, with three species alone (maize, rice and wheat) ac-
counting for about 90% of the total production. Although wheat is
third in order of total production, with about 713 m tonnes grown
in 2013 compared with 745 m tonnes of rice and 1017 m tonnes of
maize (http://faostat.fao.org/site/339/default.aspx), it has the wid-
est geographical distribution, being grown and consumed as a
staple food between 67N in Scandinavia and 45S Argentina
(Feldman, 1995), and in both highly industrialised western econo-
mies (Western Europe, North America) and in developing econo-
mies (China, Brazil, India). Hence it can be argued that wheat is the
most important crop in the world in its global impact on human
nutrition. Wheat consumption is also increasing globally, For
example, the availability of wheat as a %age of total kCal in food
increased from 11.85 in 1961 to 24.41% in 2011 in India, and from
12.20% to 17.83% in China (FAO Food Balance Sheets http://faostat3.arpenden, Hertfordshire AL5
.R. Shewry).
r Ltd. This is an open access articlefao.org/faostat-gateway/go/to/download/FB/FBS/E). Furthermore,
demand is increasing dramatically in industrialising countries in
which the production of wheat is limited by climatic conditions,
such asWest Africa (e.g. an increase from 0.89% to 6.64% of the total
available kCal in Nigeria between 1961 and 2011).
Within these countries wheat makes important contributions to
diet and health, particularly the provision of dietary ﬁbre, B vita-
mins (notably vitamins B1, B2, B3, B6 and B9 (folates)) and mineral
micronutrients (notably Fe, Zn, Se). This contribution is most
readily demonstrated for developed economies where accurate
data are available on food intakes. For example, the UK National
Diet and Nutrition Survey (NDNS) showed that cereals account for
31% (and breads for 10e12%) of the total daily intake of energy in
adults between the ages of 19 and 64, 23% (breads for 10e11%) of
the total daily intake of protein, 37e40% (breads for 18e21%) of the
total daily intake of non-starch polysaccharides (ie dietary ﬁbre),
38e40% (breads for 15e16%) of the total daily intake of Fe and 27%
(breads 12%) of the total daily intake of folates (https://www.gov.
uk/government/publications/national-diet-and-nutrition-survey-
results-from-years-1-to-4-combined-of-the-rolling-programme-
for-2008-and-2009-to-2011-and-2012).
Vitamins and minerals have long been known to be essential for
human health, while cereal dietary ﬁbre has been shown to reduce
the risk of a range of chronic diseases (including cardio-vascular
disease, type 2 diabetes and colo-rectal cancer (Topping, 2007;under the CC BY license (http://creativecommons.org/licenses/by/4.0/).
Fig. 1. The groups of gliadin and glutenin proteins separated by electrophoresis at low
pH and SDS-PAGE, respectively. Taken from Shewry et al. (1999) with permission.
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2011; Threapleton et al., 2013; Laﬁandra et al., 2014; SACN, 2014).
In addition, wheat is rich in a range of phytochemicals, notably
phenolic acids and other phenolic compounds, which have been
reported (but not conclusively established) to have beneﬁts in
reducing the risk of chronic diseases. Hence, restricting the intake
of wheat in the diet can have serious consequences for the intake of
essential nutrients and other beneﬁcial components unless equiv-
alent sources of these are provided.
Almost all of the wheat consumed by humans undergoes
extensive processing before consumption. This usually comprises
two stages. Firstly, the grain is milled to give ﬁne particles and, in
most cases, to separate the starch-rich endosperm (which is the
origin of white ﬂour) from the outer layers (aleurone, pericarp and
testa) and germ (which together form the bran). Secondly, the ﬂour
is processed into various foods, most commonly bread but also
other baked goods (cakes, biscuits), noodles (bread wheat) and
pasta (durumwheat) and breakfast cereals. Wheat ﬂour, and gluten
(see below), are also widely used as ingredients in the food
industry.
1.2. Wheat gluten proteins
The use of wheat for most food products in underpinned by the
gluten proteins. These correspond to the major group of grain
storage proteins which are deposited in the starchy endosperm
cells to support germination and seedling growth. They account for
up to 80% of the total grain proteins, which in turn account for
between 10 and 15% of the dryweight of grain grown commercially.
These proteins form a continuous matrix surrounding the starch
granules in the mature starchy endosperm cells, and are brought
together to form a continuous network when ﬂour is mixed with
water to give dough. This network confers a unique combination of
elasticity and viscosity which enable the dough to be processed into
the range of products discussed above. Although related proteins
are present in other temperate cereals (barley, rye and oats) they do
not share the same properties and it is necessary to blend them
with wheat ﬂour to make products which are acceptable to most
consumers. It is therefore crucial that any modiﬁcations that are
made to the amount and composition of the gluten proteins should
also be considered in relation to their effects on the biophysical and
functional properties of dough.
Wheat gluten proteins are traditionally classiﬁed into two
groups based on their solubility. The gliadins are readily extracted
from ﬂour with alcohol:water mixtures, such as 60% (v/v) ethanol
or 50% (v/v) propan-1-ol, while the glutenins were traditionally
extracted with dilute acid or alkali. However, these fractions
contain related proteins and the differences in solubility are
determined by their presence as monomers or polymers. Thus, the
gliadin fraction comprises mainly proteins which are present as
monomers, with small amounts of polymeric components, while
the glutenins comprise “subunits” assembled into high molecular
mass polymers stabilized principally by inter-chain disulphide
bonds. When these disulphide bonds are reduced the monomeric
glutenin subunits resemble the gliadins in being soluble in alco-
hol:water mixtures. Hence, the protein subunits present in both
fractions correspond to alcohol-soluble prolamin proteins as
deﬁned in the classic studies of Osborne (1924).
Gluten protein fractions comprise many individual components,
with a high level of allelic variation in composition between cul-
tivars. The individual components can be classiﬁed on the basis of
their amino acid compositions and sequences into three families,
which have been called the sulphur-rich (S-rich), sulphur-poor (S-
poor) and high molecular weight (HMW) prolamins (Shewry et al.,
1986).The gliadins are traditionally divided based on their mobility in
electrophoresis at low pH into three groups: the S-rich a-type gli-
adins and g-type gliadins (which contain three and four inter-chain
disulphide bonds, respectively) and the S-poor u-gliadins (which
lack cysteine residues and hence do not form disulphide bonds)
(Fig. 1). Similarly, the glutenin subunits are separated by sodium
dodecylsulphate polyacrylamide electrophoresis (SDS-PAGE) into
lowmolecular weight subunits (LMW subunits) and highmolecular
weight subunits (HMW prolamins) of glutenin (Fig. 1). The LMW
and HMW subunits form inter-chain disulphide bonds which sta-
bilise the glutenin polymers, while intra-chain disulphide bonds
are also formed by LMW subunits and at least some HMW subunits.
Whereas most of the LMW subunits are S-rich and form a
distinct group within the S-rich family (B-type LMW subunits), the
fraction also contains small proportions of components that are
closely related in sequence to the a-, g- and u-gliadins. These
components correspond to “mutant” forms of gliadins in which the
presence of one or two additional cysteine residues allows their
incorporation into polymers. The LMW subunits related to u-glia-
dins correspond to one or more bands of slightly higher molecular
weight than the B-type components (called D-type LMW subunits)
and those related to g- andu-gliadins correspondmainly to a group
of bands of lower molecular weight (C-type LMW subunits). The B-
type LMW subunits can be further sub-divided based on their N-
terminal amino acids: M (methionine) or S (serine). There are also
clear differences between the amino acid sequences of the u-glia-
dins encoded by chromosomes 1A and 1D and those encoded by
chromosome 1B (also called u5-gliadins): these relate to their
toxicity in coeliac disease and are discussed below.
The HMW subunits are further divided into x-type and y-type
based on their mobility on SDS-PAGE. These two types also differ in
their contents and distributions of cysteine residues.
This brief summary is based on a considerable volume of
research and the reader is referred to Shewry et al. (1999; 2003a, b;
2009) and Payne (1987) for more detailed discussions and refer-
ences. This rather complex classiﬁcation is summarized for clarity
in Fig. 2.
1.3. Wheat gluten protein genes and expressed proteins
Genetic and molecular analyses indicate that the individual
gluten proteins are encoded by multiple genes at complex loci. The
classical genetics has been reviewed in detail by Shewry et al.
(2003a). The HMW subunits of glutenin are encoded by three loci
on the long arms of the group 1 chromosomes (Glu-A1, Glu-B1, Glu-
D1), each comprising two genes encoding one x-type and one y-
type HMW subunit. Similarly, the a-type gliadins are encoded by
Fig. 2. Schematic summary of the classiﬁcation of gluten proteins. See Fig. 1 and the
text for details.
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B2, Gli-D2), 6B, 6D), but these loci are more complex and may
together comprise over 50 genes (most of which do not appear to
be expressed) (Anderson and Greene, 1997; Van Herpen et al.,
2006). The genetic control of the l-type gliadins, u-gliadins and
LMW subunits is more complex, with three major loci for each (Gli-
A1, Gli-B1, Gli-D1 and Glu-A3, Glu-B3, Glu-D3, respectively) located
on the short arms of the group 1 chromosomes. However, a number
of minor loci encoding both gliadins and LMW subunits have been
mapped to the same chromosome arms.
The major gliadin and LMW subunit loci are clearly multigenic.
Qi et al. (2009) reported 29 functional l-gliadin genes in Chinese
Spring wheat but Anderson et al. (2013) only 11 functional genes in
the same variety. Multiple u-gliadin genes are also present at the
Gli-3 loci (Sabelli and Shewry, 1991; Anderson et al., 2009). Cassidy
et al. (1998) reported 17 genes for B-type LMW subunits; the genes
encoding C-type and D-type subunits can be expected to be
included in those reported for the corresponding gliadin gene
families, as discussed by Anderson et al. (2009) for the D-type LMW
subunits and u-gliadins.
More realistic estimates of the numbers of expressed gluten
proteins are provided by proteomic studies. For example, Dupont
et al. (2011) reported 5 HMW subunit proteins, 22 LMW subunit
proteins, 13 g-gliadins, 13 a-gliadins and 7 u-gliadins in the cultivar
Butte 86.2. Coeliac disease and the identiﬁcation of toxic motifs in
wheat
2.1. Intolerance and allergy to wheat
Coeliac disease (CD) is one of a number of diseases associated
with the ingestion of the gluten proteins of wheat and related
prolamins of barley, rye and, in some individuals, oats. CD is clas-
siﬁed as a Tcell-mediated autoimmune disease (Sapone et al., 2012)
in which the ingestion of prolamins results in the ﬂattening of the
villi in the intestinal tract and the subsequent malabsorption of
nutrients. It is one of the commonest food intolerances, with an
incidence of approx. 1% of the population (Biagi et al., 2010). Two
much rarer forms of intolerance which are related to CD have been
described: these are dermatitis herpetiformis (DH) and gluten
ataxia (GA). DH is described as the skin manifestation of CD, pre-
senting as a rash and IgA deposits in the skin and affects one to sixper 10,000 of the population (Salmi et al., 2011). In GA, antibodies
produced against the prolamins cause damage to the cerebellum
(the part of the brain responsible for balance and motor control)
(Hadjivassilou et al., 2008). For all three conditions the only treat-
ment is a strict gluten free diet (Sapone et al., 2012).
Cereal allergies also involve the immune system, but in this case
the response is mediated by the production of IgE. Cereal allergies
comprise respiratory allergy (bakers' asthma), food allergy, contact
urticarial and wheat-dependent exercise-induced anaphylaxis
(WDEIA). In addition to prolamins, reported allergens include al-
bumins, globulins and other proteins of wheat (Tatham and
Shewry, 2008). Of the cereal allergies, only WDEIA has been char-
acterised in detail, showing the presence of epitopes in the proline
and glutamine-rich repetitive domains of the u5-gliadins (B
genome encoded) and HMW subunits of wheat glutenin (Matsuo
et al., 2004). In other forms of cereal allergy, the causative aller-
gens are more heterogeneous, comprising prolamin and non-
prolamin proteins. These conditions will not be considered
further here.
CD is the commonest food intolerance and appears to be
increasing in prevalence, although the reasons for this are currently
unclear (Catassi et al., 2007). However, the increasing consumption
of wheat in the place of traditional foods (non-gluten containing
cereals such as maize and sorghum, and tubers) in Africa and Asia
(discussed earlier) may lead to an increase in CD in these countries.
CD is strongly associated with speciﬁc genetic backgrounds,
particularly with the genes encoding the HLA-DQ2 and DQ8 sero-
type groups, with 95% of CD patients exhibiting the DQ2 serotype
class (see Scherf, Koehler & Wieser, this volume).
2.2. Identiﬁcation of coeliac disease epitopes
Currently thirty-one, nine amino acid peptide sequences in the
prolamins of wheat and related species have been deﬁned as being
coeliac toxic: these are often referred to as coeliac “epitopes”.
However, mapping is incomplete and the number of distinct epi-
topes a matter of on-going discussion (Sollid et al., 2012). These
epitopes are located in the repetitive domains of the prolamins,
which are proline and glutamine-rich, and the high levels of proline
in their sequences may reduce their susceptibility to protease ac-
tivity in the GI tract. The prolamin-reactive T cells (T lymphocytes)
of CD patients also recognise these epitopes to a greater extent
when speciﬁc glutamine residues in their sequences have been
deamidated to glutamic acid by a tissue transglutaminase (tTG2).
This binding enables the formation of a stable peptide-MHC com-
plex, which is important in the anti-prolamin T-cell response (Sollid
et al., 2012).
The majority of coeliac toxic peptides have been identiﬁed from
in vitro studies using peptides cultured with T cell lines or T cell
clones derived from the biopsied small intestinal mucosa of CD
patients (Carmarca et al., 2012). Anderson et al. (2000) developed
an in vivo method, reporting that T cells recognised the same pro-
lamin epitopes in the peripheral blood of CD patients after oral
gluten challenge as those identiﬁed by organ culture. The current
list of Tcell prolamin epitopes recognised by Tcells is a combination
of peptides identiﬁed by these two methods (Sollid et al., 2012).
Camarca et al. (2009) reported considerable variation in the T cell
responses of fourteen coeliac patients, which would indicate that
there are probably far more active epitopes than listed by Sollid
et al. (2012).
Tye-Din et al. (2010) reported a hierarchy of coeliac-stimulating
peptides after challenge with wheat, barley and rye. This showed
that the immunodominant sequence after wheat challenge corre-
sponds to a well-characterised 33 residue peptide from a-gliadin
that contains the overlapping T-cell epitopes DQ2.5-glia-a1a, b and
Table 2
List of coeliac disease relevant T-cell epitopes from wheat,
barley and rye. Glutamine residues deamidated by tissue
transglutaminase are shown in bold, additional glutamine
residues targeted by transglutaminase are underlined. The
sequences were used to map the epitopes on to prolamin
sequences from the GenBank database, which are shown in
Fig. 3. Adapted from Sollid et al. (2012).
Epitope Sequence
DQ2.5 restricted epitopes
Wheat
DQ2.5-glia-a1a PFPQPQLPY
DQ2.5-glia-a1b PYPQPQLPY
DQ2.5-glia-a2 PQPQLPYPQ
DQ2.5-glia-a3 FRPQQPYPQ
DQ2.5-glia-g1 PQQSFPQQQ
DQ2.5-glia-g2 IQPQQPAQL
DQ2.5-glia-g3 QQPQQPYPQ
DQ2.5-glia-g4a SQPQQQFPQ
DQ2.5-glia-g4b PQPQQQFPQ
DQ2.5-glia-g4c QQPQQPFPQ
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tion (with pepsin and trypsin) and was initially identiﬁed as the
major coeliac toxic peptide in the gliadins. Whereas most previous
studies concentrated on wheat, Tye-Din et al. (2010) extended
studies to barley and rye and reported that the peptides that
stimulated T cells were the same among patients that consumed
the same cereal, but were different after wheat, barley and rye
ingestion. However, analysis after oral challenge with a mixture of
prolamin fractions from wheat, barley and rye showed that se-
quences derived from S-poor prolamins (u-gliadins, u-secalins and
C hordeins) were immunodominant. Coeliac toxic peptide epitopes
from barley and rye are located in the S-poor C hordeins and u-
secalins, respectively (Sollid et al., 2012). Hence, Tye-Din et al.
(2010) concluded that the S-poor derived epitopes DQ2.5-gli-u1
and DQ2.5-gli-u2 were also immunodominant in HLA-DQ2 asso-
ciated CD. Furthermore they reported that T cells speciﬁc for a
restricted number of peptides accounted for most prolamin speciﬁc
T cell responses.DQ2.5-glia-g4d PQPQQPFCQ
DQ2.5-glia-g5 QQPFPQQPQ
DQ2.5-glia-u1 PFPQPQQPF
DQ2.5-glia-u2 PQPQQPFPW
DQ2.5-glut-L1 PFSQQQQPV
DQ2.5-glut-L2 FSQQQQSPF
Barley
DQ2.5-hor-1 PFPFPQQPF
DQ2.5-hor-2 PQPQQPFPQ
DQ2.5-hor-3 PIPQQPQPY
Rye
DQ2.5-sec-1 PFPQPQQPF
DQ2.5-sec-2 PQPQQPFPQ
DQ2.2 restricted epitopes
Wheat
DQ2.2-glut-L1 PFSQQQQPV
DQ8 restricted epitopes
Wheat
DQ8-glia-a1 QGSFQPSQQ
DQ8-glia-g1a QQPQQPFPQ
DQ8-glia-g1b QQPQQPYPQ
DQ8-glut-H1 QGYYPTSPQ
DQ8.5 restricted epitopes
Wheat
DQ8.5-glia-a1 QGSFQPSQQ
DQ8.5-glia-g1 PQQSFPQQQ
DQ8.5-glut-H1 QGYYPTSPQ2.3. Distribution of coeliac disease epitopes
Information on the frequency, distribution and immunodomi-
nance of coeliac toxic epitopes is required to underpin the use of
conventional breeding or genetic engineering to develop lines with
reduced CD toxicity. Table 2 shows the current list of T-cell epitopes
for wheat, barley and rye (Sollid et al., 2012) and Fig. 3 their dis-
tribution in the amino acid sequences of representative prolamins.
The sequences were selected from the GenBank database and
mapped for the un-deamidated forms of the coeliac toxic peptide
identiﬁed by Sollid et al. (2012). Although these sequences were
selected as representative of the different types of wheat prolamin
they do not feature all of the epitopes listed by Sollid et al. (2012).
In the a-type gliadins the epitopes are predominantly distrib-
uted in the N-terminal repetitive domain while in the g-type glia-
dins they are more widely distributed with a higher frequency of
occurrence. The repetitive domain of the g-type gliadin sequence
shown in Fig. 3 contains the epitope (DQ2.5-glia-u1) associated
with the S-poor prolamins and epitopes for both HLA-DQ2 and DQ8
serotype groups.
There is a marked difference in the distributions of epitopes
between the u-gliadins encoded by the A/D genomes and B
genome of bread wheat: whereas epitopes are distributed
throughout the sequences of the chromosome A/D encoded u-gli-
adins they are absent from the B-encoded u-gliadins (u5-gliadins).
However, Vader et al. (2002) reported a T-cell stimulatory sequence
(Glu-5: QIPQQPQQF) that is u5-gliadin-derived and present at
multiple sites. It is therefore unlikely that this class of u-gliadins is
devoid of coeliac toxic peptides. The presence of shared epitopes in
the chromosome A/D encoded u-gliadins and the g-gliadins is to beTable 1
Summary of the major cultivated and wild species of wheat (based on Feldman, 1995).
Ploidy genome Wild species
diploid
D T. tauschii
A T. urartu
A T. monocucum var. boeticum
tetraploid
A B T. turgidum var. dicoccoides
hexaploid
A B D
a Free threshing forms.expected given the similarity between the repetitive domains of
these two types of protein. Similarly, the u-secalins of rye and C
hordeins of barley are closely related to the A/D genome encoded
u-gliadins of wheat and show similar distributions of epitopes (the
DQ2.5-gli-u1, DQ2.5-hor-1 and DQ2.5-sec-1 epitopes being ho-
mologous). This similarity has been proposed as the basis for the
cross-reactivity betweenwheat, barley and rye prolamins, as barleyCultivated species
T. monococum var. monococum einkorn
T. turgidum var. dicoccum emmer
T. turgidum var. durum duruma
T. aestivum var. aestivum breada
wheat
T. aestivum var. spelta spelt
Fig. 3. Coeliac toxic epitope distribution in representative prolamins identiﬁed by
GenBank accession code and T-cell epitopes from Sollid et al. (2012). a-gliadin P18573:
DQ2.5-glia-a1a, DQ2.5-glia-a1b, DQ2.5-glia-a2 & DQ8-glia-a1. g-gliadin AAK84774:
DQ2.5-glia-u1/hor-1/sec-1, DQ8-glia-g1a, DQ8-glia-g2, DQ8-glia-g4c & DQ8-glia-g5.
u-gliadin (A/D) AAT74547: DQ2.5-glia-g5, DQ8-glia-g1a, DQ2.5-glia-u1/hor-1/sec-1,
DQ8-glia-g1b & DQ2.5-glia-g3. u-gliadin (B) AB181300 no coeliac toxic epitopes
present. LMW subunit AAS66085:DQ2.5-glut-L1. HMW Subunit (1Bx17) BAE96560:
DQ8.5-glut-H1. HMW Subunit (1Dy10) AAU04841: DQ8.5-glut-H1. u-secalin
ACQ83628: DQ2.5-glia-g5 & DQ2.5-glia-u1/hor-1/sec-1. C hordein: DQ2.5-glia-g5,
DQ8-glia-g1a & DQ2.5-glia-u1/hor-1/sec-1.
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and a-gliadin type epitopes are therefore absent (Tye-Din et al.,
2010). The LMW subunit sequence AAS66085 contains one
epitope (DQ2.2-glut-L1) as do the x- and y-type HMW subunits of
glutenin (DQ8.5-glut-H1), with both epitopes being repeated in the
sequences. The number of DQ8 epitopes is less than those of DQ2
epitopes in all sequences apart from the HMW subunits, where
they are the only epitopes present and are distributed throughout
the sequences.
Mutagenesis has been used to determine the importance of
individual amino acid residues in coeliac epitopes, and identify
substitutions that eliminate activity. For example, Anderson et al.
(2006) mutated the sequences DQ2.5-glia-a1a and DQ2.5-glia-a2
and found that single substitutions abolished activity. These studies
are important as the provide a basis for identifying naturally
occurring “coeliac-safe” variants of prolamins in wheat lines, and
targets for molecular breeding approaches. These are discussed
below.3. Reducing coeliac toxicity by exploiting natural variation in
cultivated wheat and wild relatives
3.1. Genetic diversity of wheat
Wheat occurs in a range of diploid, tetraploid and hexaploid
forms (summarised in Table 1). The earliest cultivated forms were
the A genome diploid einkorn (T. monococcum var monococcum)
and tetraploid emmer (T. turgidum var. dicoccum) with the A and B
genomes. These are closely related to wild forms: diploid
T. monococcum var. monococcum and T. ururtu and tetraploid
T. turgidum var. dicoccoides, respectively. Modern tetraploid durum
(pasta) wheat (T. turgidum var. durum) probably arose from muta-
tions in cultivated emmer.
Hexaploid bread wheat (Triticum aestivum) (genomes ABD) has
never existed as a wild species and no wild hexaploid wheats are
known. It probably arose by hybridization of cultivated emmerwith
the related wild grass T. tauschii (goat grass, also called Aegilops
tauschii and Ae. squarossa). This hybridization probably occurred in
south-eastern Turkey about 9000 years ago (Feldman, 1995;
Dubcovsky and Dvorak, 2007) and contributed the D genome. All
cultivated hexaploid wheats, including spelt, are forms of
T. aestivum.
A major difference between “ancient” cultivated wheats
(einkorn, emmer, spelt) and their wild relatives andmodern durum
and bread wheats is whether the grain are hulled or free threshing.
In hulled wheats the glumes and palea adhere to the grain and the
threshed material consists of intact spikelets. By contrast, these
structures are removed in “free threshing” durum and bread
wheats and the harvested material consists of caryopses. The hul-
led einkorn, emmer and spelt are together called “faro” in Italy. The
reader is referred to Feldman (1995), Dubcovsky and Dvorak (2007)
and chapters in Elsayed and Wood (2005) for detailed discussions
of the evolutionary relationships of wheat species and the char-
acteristics of the “ancient” cultivated forms.
Ancient wheats do not contribute signiﬁcantly to global wheat
production but there is increasing demand, particularly for spelt,
due to perceived health beneﬁts. They therefore have high value
market value and are frequently produced using traditional or
organic farming systems. For example, about 2.5% of the certiﬁed
organic wheat grain grown in the USA in 2011 was spelt (http://ers.
usda.gov/Data-products/organic-production.aspx).
Wild tetraploid and diploid wheats can be readily crossed with
their cultivated counterparts to transfer genes and traits, as can
cultivated spelt and bread wheats. In addition, genes and traits can
be transferred between species with different ploidy levels
(Mujeeb-Kazi et al., 2013). It is also possible to “resynthesize”
hexaploid wheat, by crossing cultivated durum wheat with diploid
T. tauschii (Ogbonnaya et al., 2013).
Despite its recent origin, bread wheat shows immense diversity.
Feldman (1995) estimated the existence of about 25,000 cultivars/
lines and the true number is likely to be substantially greater than
this. A survey of accessions in gene banks carried out in 2010 re-
ported a total of over 850,000 accessions of “wheat” (including
advanced and old cultivars, land races, breeding lines and wild
species) in 230 collections, the largest being over 110,000 acces-
sions held at CIMMYT in Mexico (http://www.fao.org/docrep/013/
i1500e/i1500e12.pdf). This represents an immense resource for
wheat improvement.
3.2. Exploiting genetic diversity in gluten proteins to reduce coeliac
toxicity
The improvement of wheat and other crops by plant breeding is
based on the identiﬁcation of genetic variation in traits of interest
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competitive in terms of their yield, agronomic performance and
quality. In the case of coeliac toxicity, the trait of interest is the
number and distribution of coeliac toxic sequences (epitopes). It is
therefore logical to determine the relative distribution of coeliac
epitopes within different gluten protein types (which is discussed
above), and how this distribution varies between proteins coded by
the three genomes of hexaploid bread wheat and between the
genotypes, including modern commercial cultivars, exotic lines
from other parts of the world and “land races” which were culti-
vated before the use of modern intensive breeding.
3.2.1. a-gliadins
As the most coeliac-active T-cell epitopes are present on the a-
gliadins, emphasis has been placed on exploring differences in the
amounts and sequences of proteins of this class. Kasarda et al.
(1976) used genetic stocks (inter-varietal substitution lines and
nullisomic-tetrasomic lines) to map the highly coeliac-active A-
gliadin fraction (which comprises a-gliadins) to genes present on
chromosome 6A and it was suggested that nullisomic-tetrasomic
lines could be used to produce bread for people with coeliac dis-
ease (Tucic et al., 1978). Support for this was provided by a pre-
liminary study, in which no adverse reactions were reported in two
patients who were fed bread made with nulli-6A wheat (Kasarda
et al., 1978). However, Ciclitira et al. (1980a,b) subsequently
showed adverse reactions when oral challenges were carried out in
two coeliac patients fed bread made with either nulli-6A tetra-6D
or nulli-6A tetra-6B wheat. Nevertheless, a more recent in vitro
study using coeliac mucosa and peptic-tryptic digests of total
gluten showed a signiﬁcant reduction in toxicity in in a naturally
occurring mutant line which lacked the Gli-A2 locus on chromo-
some 6A (Frisoni et al., 1995). It should be noted that this line
differed from those used by Kasarda et al. (1978) and Ciclitira et al.
(1980a,b) in that the absence of the a-type gliadins encoded by the
Gli-A2 locus was not accompanied by compensatory increases in
the a-type gliadins encoded by Gli-B2 or Gli-D2. It therefore sup-
ported the initial suggestion that the use of lines lacking in a-gli-
adins encoded by chromosome 6A could contribute to the
production of wheat with reduced coeliac toxicity.
Carroccio et al. (2011) have since described the production of a
wheat line (C1173) which lacks the a-type gliadins encoded by Gli-
A2 locus and also g-gliadins and u-gliadins encode by the complex
Gli-D1/Glu-D3 locus. Prolamins from this line showed signiﬁcantly
lower toxicity in vitro than a similar fraction from the control line
San Pastore.
van den Broeck et al. (2009) have screened gluten protein
fractions from lines of Chinese Spring wheat with partial deletions
of the long and short arms of the group 6 chromosomes using
monoclonal antibodies that recognise T-cell epitopes. Loss of the a-
gliadin locus from the short arm of chromosome 6D resulted in a
signiﬁcant decrease in the presence of T-cell stimulatory epitopes
but also a signiﬁcant loss of dough functionality. This is consistent
with the studies of van Herpen et al. (2006) who showed that T-cell
stimulatory epitopes weremore abundant in a-gliadins encoded by
the D genome, and Molberg et al. (2005) who demonstrated that
the immunodominant 33mer fragment of a-gliadinwas encoded by
chromosome 6D (and hence absent from diploid einkorn and
tetraploid wheats). A subsequent study also showed that the
detrimental effect of the loss of chromosome 1DS on functionality
could be compensated for by adding coeliac-safe avenin proteins
from oats (van den Broeck et al., 2011).
Variation in the distribution of coeliac toxic motifs between
wheat genomes, genotypes and species has been reported in a se-
ries of studies, particularly from workers at Plant Research Inter-
national, Wageningen (NL). Early work from this group incollaboration with the group of Frits Koning at the University of
Leiden (Spaenij-Dekking et al., 2005) surveyed the distribution of T-
cell stimulatory epitopes in gluten protein sequences in the Uniprot
protein sequence database. This showed that T-cell stimulatory
sequences were present in 66% (19/29) of a-gliadin sequences.
More detailed studies of the a-gliadin gene family were re-
ported by van Herpen et al. (2006) who combined data on bread
wheat from public databases with the cloning and sequencing of
genomic DNA from diploid wheats with ancestral A, B and D ge-
nomes. The use of genomic DNA meant that both expressed genes
and silent pseudogenes were ampliﬁed from the diploid wheats,
with at least some of the latter being distinguishable by the pres-
ence of in frame stop codons. Analysis of the open reading frames of
the putative expressed genes (ie those without in frame stop co-
dons) for T-cell stimulatory epitopes showed that two epitopes
were present in all 15 a-gliadin sequences from T. monococcum and
all four epitopes were widely distributed in the 11 a-gliadin se-
quences from T. tauschii. However, some a-gliadin sequences fromB
genome diploids lacked T-cell stimulatory epitopes. Similar distri-
butions of T-cell stimulatory epitopes were observedwhen the data
from the diploid species were used to assign the bread wheat a-
gliadins to genomes.
Mitea et al. (2010) extended this approach, by analysing over
3000 expressed a-gliadin sequences from 11 bread wheat cultivars
that were available in public databases. About 40% of the transcripts
were assigned to Gli-A2, 25% to Gli-B2 and 35% to Gli-D2. The se-
quences were screened for the presence of ﬁve peptide sequences
involved in coeliac disease (DQ2-Glia-a1, DQ2-Glia-a2, DQ2-Glia-
a3, DQ8-Glia-a1 and P31-43). Variant forms of these epitopes were
then tested as synthetic peptides against a-gliadin speciﬁc T-cell
clones. This demonstrated that several naturally occurring amino
acid substitutions eliminated the antigenic activity of the peptides.
In particular, naturally occurring and introduced substitutions of
serine for proline at speciﬁc positions in the a-gliadin epitopes
abolished their antigenic properties. The authors therefore sug-
gested that the selection of such mutations constituted a universal
approach to eliminate coeliac-toxicity from wheat cultivars.
However, van Herpen et al. (2006) noted that differences in gene
expression levels must also be taken into account and screening of
gluten protein fractions for T-cell stimulatory epitopes using T-cell
based and monoclonal antibody assays showed that differences in
levels of expression occurred both within and between species
with different genome constitutions (Spaenij-Dekking et al., 2005).
Transcriptome analysis also showed wide differences between the
expression of genes encoded by chromosomes A, B and D in bread
and durumwheats. For example, the expression of genes at the Gli-
A2 locus varied from 12% to 58% of total a-gliadin transcripts in
landrace genotypes (Salentijn et al., 2009).
As discussed above, the absence of the D genome from durum
wheat could result in lower coeliac activity due to the absence of
the T-cell stimulatory epitopes at the Gli-D2 locus. van den Broeck
et al. (2010a) therefore screened 103 accessions of tetraploid wheat
by immunoblotting of gluten protein extracts with monoclonal
antibodies against the Glia-a9 and Glia-a20 epitopes. This identi-
ﬁed three accessions with signiﬁcantly reduced levels of both epi-
topes. Further analysis of 61 durum wheat accessions by high
throughput transcript sequencing similarly identiﬁed some acces-
sions with lower abundances of transcripts containing coeliac dis-
ease epitopes (Salentjin et al., 2013).
Finally, van den Broeck et al. (2010b) compared the abundance
of the major Glia-A9 coeliac disease epitope in 36 modern wheat
cultivars and 50 land races by immunoblotting of gluten protein
extracts, using the minor Glia-A20 epitope as a technical reference.
The modern cultivars tended to show higher reactivity with the
Glia-A9 antibody and lower reaction with the Glia-A20 antibody,
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bodies were present in both sets of germplasm.
3.2.2. Other gluten proteins
Although impressive progress has been made with identifying
variation in the abundances of coeliac disease epitopes in a-glia-
dins, it must be borne in mind that other groups of gluten protein
also contain coeliac active sequences.
This was demonstrated in the survey of gluten protein se-
quences in the Uniprot protein sequence database by Spaenij-
Dekking et al. (2005) which is referred to above. They showed
that T-cell stimulatory epitopes were present in all g-gliadin se-
quences (17/17), in 95.5% (21/22) of HMW subunit sequences and in
5% of LMW subunit sequences (3/57), in addition to 66% (19/29) of
a-gliadin sequences. Similarly, the analysis of Chinese Spring
deletion lines reported by van der Broeck et al. (2009) showed that
the loss of gliadins and LMW subunits encoded by the short arm of
chromosome 1DS removed T-cell epitopes but had little impact on
functionality (in contrast to the deletion of the a-gliadin genes on
chromosome 6D).
Salentijn et al. (2012) assigned g-gliadin transcript sequences to
bread wheat genomes based on comparisons with genomic se-
quences from related diploid sequences. This showed that g-glia-
dins encoded by the Gli-D1 locus accounted for almost half of the
total g-gliadin transcripts in bread wheat and also had higher
contents of coeliac disease epitopes than the g-gliadins encoded by
Gli-A1 and Gli-B1.
3.3. Developing coeliac-safe wheat
The detailed studies discussed above clearly demonstrate that
there is extensive variation in the occurrence of coeliac-toxic epi-
topes within and between the sequences of gliadins encoded by the
three genomes of bread wheat (and the corresponding genomes of
diploid and tetraploid species), and in the levels of expression of
these proteins. Although in some cases these include the existence
of forms that lack the currently deﬁned coeliac epitopes, it cannot
be ruled out that they contain sequences which will stimulate a
response in some individuals. Nevertheless it should be possible to
exploit this variation to develop wheat cultivars with low levels of
these epitopes, if not their absence. However, there are several
factors to consider.
Firstly, the studies have focused on a small number of major
epitopes in a-gliadins. Although these are the most important in
relation to stimulating a response in susceptible individuals, we
know that many more epitopes exist (as discussed above) (Sollid
et al., 2012).
Secondly, the gliadins and glutenins are encoded by genes in
complex multigenic loci and recombination within these loci oc-
curs only rarely. Hence, it will be necessary to select for groups of
gluten proteins rather than single components. It will also be
necessary to develop tools to enable wheat breeders to select
appropriate progeny in their programmes.
Thirdly, the impact of such selection on the yield and processing
quality of the lines must be considered, as discussed below.
4. Reducing coeliac toxicity by molecular breeding
4.1. Mutagenesis
The treatment of plants with radiation or chemical agents to
induce mutations is an effective way to generate novel genetic di-
versity and has been used to produce over 3000 crop cultivars
(http://mvgs.iaea.org/Default.aspx). However, whereas morpho-
logical traits are readily identiﬁed, screening for biochemical orfunctional traits can be time consuming and expensive. The appli-
cation to polyploids also poses an additional challenge in that most
induced mutations are recessive. Consequently, where gene ho-
mologues are expressed on two or more genomes it is necessary to
identify and combine mutations in them in order to observe a
phenotype.
In recent years, the identiﬁcation of mutations at the gene
sequence level has been facilitated by the development of PCR-
based screening, a technology known as TILLING (Targeting
Induced Local Lesions in Genomes) (McCallum et al., 2000). Seeds
are treated with chemical agents such as sodium azide (NaN3) or
ethyl methane sulphonate (EMS) to induce point mutations which
are randomly distributed over the entire genome. These will
includemutations of several types: nonsensemutations whichmay
cause loss of gene function, by truncation or loss of expression of
corresponding protein; missense mutations which result in the
change of an amino acid in the protein encoded by the mutated
gene; and silent mutations which have no effect on the protein
sequence or functionality. TILLING can also be used identify genetic
variation in natural populations, an approach termed EcoTILLING
(Comai et al., 2004). Mutagenized populations and TILLING plat-
forms are now widely available for wheat, including einkorn,
durum and bread wheats (Slade et al., 2005; Chen et al., 2012;
Rawat et al., 2013; Bovina et al., 2014), and this approach has
been successfully applied for identifying mutations affecting starch
synthesis and composition (Slade et al., 2012; Uauy et al., 2009;
Sestilli et al., 2010).
However, the application of TILLING to manipulating gluten
protein content and composition is clearly more challenging due to
the complexity of the gluten protein loci with multiple expressed
genes. It is clearly not realistic to attempt to modify the amino acid
sequences of over 50 expressed gluten proteins but it may be
possible to speciﬁcally up- and/or down-regulate the genes
encoding speciﬁc groups or families of gluten proteins to manip-
ulate the balance of coeliac toxic to not-toxic proteins. Some suc-
cess has been achieved by using this approach in transgenics
(below).
4.2. Transgenesis
The transformation of both bread and durum wheats is now
established in a number of laboratories worldwide, using either
biolistics or Agrobacterium-mediated systems (see, for example,Wu
et al., 2009; Sparks and Jones, 2009). This allows both the addition
of novel genes, and the down-regulation of endogenous genes us-
ing RNAi technology.
This approach was ﬁrst used by Becker and co-workers (Becker
et al., 2006; Becker and Folck, 2006; 2012; Wieser et al., 2006a, b),
who reported down-regulation of a-gliadins in a series of RNAi
lines. Wieser et al. (2006a,b) and Becker et al. (2012) reported
detailed analyses of ﬂour from a mixture of two transgenic lines, in
which a-gliadins were reduced by over 60% compared to the con-
trol cultivar. The down-regulation of a-gliadins was associated with
compensatory increases in albumins, globulins, other gliadins and
LMW subunits, with an overall reduction in total gluten proteins of
about 9%. Whereas the dough resistance and extensibility of the
two lines were similar, the transgenic line had stronger gluten: this
probably related to a decrease in the gliadin:glutenin ratio resulting
from the decrease in a-gliadins. The volume of bread baked from
the transgenic line was also slightly lower, but the crumb structure
and appearance similar. Silencing of the u5-gliadins has also been
achieved by transgenesis, with improvement in dough mixing
quality. Such lines would be beneﬁcial for patients withWDEIA and
food allergy to wheat (Altenbach and Allen, 2011; Altenbach et al.,
2014).
P.R. Shewry, A.S. Tatham / Journal of Cereal Science 67 (2016) 12e21 19More extensive studies have been reported by the group of
Francisco Barro, who generated two series of lines, with down-
regulation of only g-gliadins (Gil-Humanes et al., 2008; Piston
et al., 2011) or all gliadins (a-, g- and u-) (and in one line also
LMW subunits) (Gil-Humanes et al., 2010, 2011). This work has
been recently reviewed in detail in this journal (Rosell et al., 2014)
and will therefore only be brieﬂy described here. The g-gliadin
RNAi lines showed between 65% and 97% reduction in the target
proteins, with some effects on the mixing and bread making per-
formance. However, as with the a-gliadin suppressed lines dis-
cussed above, they also had greater dough strength and resistance
to over-mixing (Gil-Humanes et al., 2012, 2012a,b). The second
series of lines had reductions of between 60% and 88% in their
contents of all gliadins. The transgenic lines generally had weaker
dough than the control, but some also had greater stability (which
should confer greater tolerance to over-mixing (Gil-Humanes et al.,
2014b). There was also a severe effect on loaf volume, which was
reduced by between about 20% and 30% compared to the controls,
but the sensory properties were similar to the controls (Gil-
Humanes et al., 2014a). However, tests with T-cell clones derived
from intestinal lesions of coeliac patients showed that there was
also an almost complete suppression of disease-related T-cell epi-
topes (Gil-Hermanes et al., 2010).
Whereas the studies described above directly targeted the
expression of gluten protein genes, Wen et al. (2012) used RNAi to
target the gene encoding a demethylase enzyme responsible for the
transcriptional deregulation of gliadin and LMW subunit genes.
This resulted in between 45% and 76% suppression of the target
proteins, with some lines also showing reductions in HMW sub-
units. The impact of this suppression on celiac toxicity or func-
tionality was not determined.
4.3. Genome editing
The term genome editing is applied to a new range of technol-
ogies in which highly speciﬁc changes are made to genomes
without leaving any “footprint” in terms of the presence of foreign
DNA. They are based on the use of site-directed nucleases that are
engineered to cause breaks at speciﬁc sequences in the genome.
These breaks are then repaired by the plants' ownmechanisms, but
these are very prone to errors resulting in a high frequency of
mutations. Hence, the variation generated cannot be distinguished
from mutations which occur spontaneously at low frequencies or
are induced by mutagenesis. Three major classes of nucleases are
being exploited: zinc-ﬁnger nucleases (ZFNs), transcription
activator-like nucleases (TALENS) and clustered regularly inter-
spaced short palindromic repeats (CRISPR) nucleases. The foreign
DNA encoding the engineered nucleases may be present on a
plasmid or integrated into the genome. In either case the foreign
DNA is lost due to segregation leaving only the mutations in the
genome. For a more detailed discussion see Jones (2015).
Although transgenesis is required to introduce the nuclease
genes into the plants, the absence of foreign DNA from the prod-
ucts, and the fact that the modiﬁed sequences cannot be distin-
guished from other mutations, raises the question of whether the
products should be deﬁned as “transgenic” or not (Jones, 2015).
This is, in essence, a philosophical question about whether the
process or the product should determine the deﬁnition.
The application of genome editing to wheat is still in its infancy,
but herbicide resistant canola produced by gene editing has already
been launched for growth in North America (http://cibus.com/
press/press111914.phb).
Although several research groups are currently exploring the
application of genome editing to reduce coeliac activity the chal-
lenge posed by the presence of multiple genes and expressedproteins means that this is very much a long term target.
5. Conclusions: breeding coeliac-safe wheat
Developing coeliac-safe is clearly a realistic prospect, although a
combination of technologies may be required (classical breeding
and molecular) with a large investment of time and ﬁnancial sup-
port. However, there are major challenges to wide adoption as a
crop.
Firstly, it is necessary to retain acceptable processing quality.
This is not trivial, as the gluten proteins underpin most systems for
wheat processing, including making bread, other baked goods,
pasta and noodles. Although work carried out so far indicates that
acceptable products may be made using experimental-scale pro-
cessing, it is a much greater challenge to scale this up to industrial
scale production.
Wheat is a critical component of the diet in many low-income
countries and, as for other staple commodity crops, availability is
highly sensitive to ﬂuctuations in price. The consequences of price
rises in such crops are illustrated by the civil unrest observed in a
number of countries as a response to increases in food costs
(Schneider, 2008). The high cost of cultivar development, increased
raw material costs associated with detrimental effects on agro-
nomic performance and yield, and increased processing costs will
almost certainly combine to result in a high cost product, at least for
the short to medium term. Hence, it likely to be more appropriate
for marketing in highly developed economies, as a more attractive
alternative to current gluten free products for coeliac patients,
rather than wider adoption to reduce the exposure of populations
to T-cell stimulatory epitopes and hence the incidence of coeliac
disease.
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